Chime (CHYM) CEO granted 900,563 stock options with monthly vesting
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Chime Financial, Inc. reported that Chief Executive Officer Christopher R. Britt received a grant of employee stock options covering 900,563 shares of Class A Common Stock. The options carry an exercise price of $21.62 per share and were reported on March 12, 2026.
According to the vesting terms, 1/48th of the option shares will vest on March 15, 2026, with 1/48th vesting monthly thereafter, subject to his continued service through each vesting date. Following this award, the filing shows option holdings of 900,563 derivative securities held directly.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Britt Christopher R
Role
Chief Executive Officer
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to buy) | 900,563 | $0.00 | -- |
Holdings After Transaction:
Employee Stock Option (Right to buy) — 900,563 shares (Direct)
Footnotes (1)
- [object Object]
FAQ
What insider transaction did Chime (CHYM) report for its CEO?
Chime reported that CEO Christopher R. Britt received an employee stock option grant for 900,563 shares of Class A Common Stock. The award is compensation-related and gives him the right to buy shares at a fixed exercise price if the options vest.
What is the exercise price of the new Chime CEO stock options?
The granted options allow CEO Christopher R. Britt to purchase Class A Common Stock at an exercise price of $21.62 per share. This price is fixed in the award and applies when vested options are exercised for underlying shares.
What is the vesting schedule for the Chime CEO’s 900,563 options?
The options vest over time: 1/48th of the shares vests on March 15, 2026, and 1/48th vests monthly thereafter. Each vesting installment requires Christopher R. Britt to remain in service through the relevant vesting date.
When do Christopher Britt’s newly granted Chime options expire?
The filing states an expiration date of March 11, 2036 for the employee stock options. Any unexercised portion of the 900,563-share grant would no longer be exercisable after that expiration date under the award’s terms.
Are the reported Chime CEO option transactions open-market purchases or sales?
The transaction is a grant or award acquisition of employee stock options, not an open-market share purchase or sale. It reflects equity compensation, with options held directly and exercisable at the stated $21.62 per share exercise price once vested.